GI
CVS icon

Gradient Investments’s CVS Health CVS Stock Holding History

Gradient Investments’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-222,938
Closed -$13.2M – 517
2024
Q2 		$13.2M Buy
222,938
+15,038
+7% +$941K 0.3% 115
2024
Q1 		$16.6M Sell
207,900
-9,138
-4% -$698K 0.38% 91
2023
Q4 		$17.1M Sell
217,038
-6,224
-3% -$443K 0.41% 78
2023
Q3 		$15.6M Sell
223,262
-2,813
-1% -$199K 0.41% 80
2023
Q2 		$15.6M Buy
226,075
+47,241
+26% +$3.36M 0.4% 87
2023
Q1 		$13.3M Buy
178,834
+25,474
+17% +$2.14M 0.36% 93
2022
Q4 		$14.3M Buy
153,360
+7,609
+5% +$734K 0.45% 73
2022
Q3 		$13.9M Buy
145,751
+4,516
+3% +$447K 0.43% 57
2022
Q2 		$13.1M Buy
141,235
+5,773
+4% +$563K 0.38% 64
2022
Q1 		$13.7M Sell
135,462
-11,165
-8% -$1.17M 0.35% 77
2021
Q4 		$15.1M Sell
146,627
-828
-0.6% -$76.5K 0.38% 56
2021
Q3 		$12.5M Sell
147,455
-207
-0.1% -$17.3K 0.35% 72
2021
Q2 		$12.3M Buy
147,662
+2,110
+1% +$173K 0.36% 59
2021
Q1 		$10.9M Buy
145,552
+2,510
+2% +$183K 0.36% 76
2020
Q4 		$8.35M Sell
143,042
-2,061
-1% -$134K 0.35% 84
2020
Q3 		$8.47M Buy
145,103
+1,860
+1% +$116K 0.36% 84
2020
Q2 		$9.31M Sell
143,243
-8,699
-6% -$548K 0.42% 69
2020
Q1 		$9.02M Buy
151,942
+151,136
+18,751% +$10.1M 0.49% 54
2019
Q4 		$60K Buy
806
+189
+31% +$13.3K ﹤0.01% 364
2019
Q3 		$39K Buy
617
+271
+78% +$16.1K ﹤0.01% 420
2019
Q2 		$19K Sell
346
-257
-43% -$13.8K ﹤0.01% 517
2019
Q1 		$33K Sell
603
-110,317
-99% -$6.81M ﹤0.01% 379
2018
Q4 		$7.27M Buy
110,920
+110,277
+17,150% +$8.23M 0.44% 66
2018
Q3 		$51K Buy
643
+21
+3% +$1.5K ﹤0.01% 359
2018
Q2 		$40K Sell
622
-822
-57% -$54.2K ﹤0.01% 369
2018
Q1 		$90K Sell
1,444
-102,998
-99% -$7.39M ﹤0.01% 281
2017
Q4 		$7.57M Buy
104,442
+16,980
+19% +$1.23M 0.44% 64
2017
Q3 		$7.11M Buy
87,462
+4,254
+5% +$337K 0.45% 56
2017
Q2 		$6.7M Buy
83,208
+4,813
+6% +$380K 0.47% 55
2017
Q1 		$6.15M Buy
78,395
+78,047
+22,427% +$6.23M 0.47% 58
2016
Q4 		$27K Buy
348
+125
+56% +$10.1K ﹤0.01% 327
2016
Q3 		$20K Sell
223
-116
-34% -$10.9K ﹤0.01% 353
2016
Q2 		$32K Sell
339
-3,525
-91% -$351K ﹤0.01% 300
2016
Q1 		$401K Sell
3,864
-379
-9% -$36.9K 0.05% 115
2015
Q4 		$415K Buy
4,243
+4,060
+2,219% +$398K 0.06% 130
2015
Q3 		$18K Buy
183
+1
+0.5% +$105 ﹤0.01% 318
2015
Q2 		$19K Sell
182
-487
-73% -$49.8K ﹤0.01% 314
2015
Q1 		$69K Buy
669
+554
+482% +$56.1K 0.01% 210
2014
Q4 		$11K Hold
115
– – ﹤0.01% 342
2014
Q3 		$9K Sell
115
-32
-22% -$2.52K ﹤0.01% 336
2014
Q2 		$11K Buy
147
+70
+91% +$5.29K ﹤0.01% 345
2014
Q1 		$6K Hold
77
– – ﹤0.01% 382
2013
Q4 		$6K Hold
77
– – ﹤0.01% 412
2013
Q3 		$4K Hold
77
– – ﹤0.01% 350
2013
Q2 		$4K Buy
+77
New +$4.46K ﹤0.01% 316

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Gradient Investments's CVS Position: Q3 2024 in Review

Gradient Investments sold out of CVS Health (CVS) in Q3 2024, closing a stake of 222,938 shares — an estimated $13.2M sold.

Gradient Investments first reported a position in CVS in Q2 2013 and held it in 45 quarters. The position peaked at $17.1M in Q4 2023. 1,840 funds tracked by Wall St. Rank hold CVS as of Q3 2024.

  • Gradient Investments reported no remaining CVS Health position as of Q3 2024 after selling out during the quarter.
  • Gradient Investments sold 222,938 CVS Health shares in Q3 2024, an estimated $13.2M.
  • Gradient Investments first reported a position in CVS Health in Q2 2013 and held it in 45 quarters.
  • Gradient Investments's CVS Health position peaked at $17.1M in Q4 2023.
  • 1,840 funds tracked by Wall St. Rank held CVS Health as of Q3 2024.

Based on Gradient Investments's 13F filing for Q3 2024, filed 15 Oct 2024.